MECAMYLAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Mecamylamine patents expire, and when can generic versions of Mecamylamine launch?
Mecamylamine is a drug marketed by Lgm Pharma and is included in one NDA.
The generic ingredient in MECAMYLAMINE is mecamylamine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mecamylamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mecamylamine
A generic version of MECAMYLAMINE was approved as mecamylamine hydrochloride by LGM PHARMA on March 19th, 2013.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MECAMYLAMINE?
- What are the global sales for MECAMYLAMINE?
- What is Average Wholesale Price for MECAMYLAMINE?
Summary for MECAMYLAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | MECAMYLAMINE at DailyMed |
US Patents and Regulatory Information for MECAMYLAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lgm Pharma | MECAMYLAMINE HYDROCHLORIDE | mecamylamine hydrochloride | TABLET;ORAL | 204054-001 | Mar 19, 2013 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
